18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments

18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments

Managing the morbidly obese patient requires an in-depth understanding of altered respiratory mechanics, hemodynamic strain, altered pharmacokinetics, and difficult airway anatomy. Anesthesia providers must apply precise weight scalars for pharmacologic agents, implement specialized preoxygenation and positioning techniques, and remain vigilant for sleep-disordered breathing syndromes.

---

1. Classification of Obesity & Weight Metrics

Body Mass Index (BMI) categorizes the degree of excess adiposity:

$\text{BMI} = \frac{\text{Weight (kg)}}{[\text{Height (m)}]^2}$

+---------------------------------------------------------------------------------------------------------+
|                                    WHO OBESITY CLASSIFICATION                                           |
+-----------------------+---------------------+-----------------------------------------------------------+
| Classification        | BMI Range (kg/m²)   | Clinical & Cardiopulmonary Implications                   |
+-----------------------+---------------------+-----------------------------------------------------------+
| **Underweight**       | < 18.5              | Frailty, malnutrition, reduced drug binding proteins      |
| **Normal Weight**     | 18.5 - 24.9         | Standard baseline physiologic parameters                  |
| **Overweight**        | 25.0 - 29.9         | Modest increase in cardiovascular risk                    |
| **Class I Obesity**   | 30.0 - 34.9         | Mild reduction in FRC and ERV                             |
| **Class II Obesity**  | 35.0 - 39.9         | Significant reduction in chest wall compliance, OSA risk  |
| **Class III Obesity** | **≥ 40.0**          | **Morbid Obesity:** Marked V/Q mismatch, severe FRC loss  |
| **Super-Obese**       | **≥ 50.0**          | Extreme risk for difficult mask/intubation, OHS, and PAH  |
| **Super-Super Obese** | **≥ 60.0**          | Severe hemodynamic compromise and biventricular strain    |
+-----------------------+---------------------+-----------------------------------------------------------+

Anthropometric Weight Scalars for Drug Dosing

1. Total Body Weight (TBW): The patient's actual measured physical weight.
2. Ideal Body Weight (IBW): Estimated normal weight for height and sex (Devine Formula): $\text{IBW}_{\text{Men}} = 50 \text{ kg} + 2.3 \text{ kg for each inch over 5 feet}$ $\text{IBW}_{\text{Women}} = 45.5 \text{ kg} + 2.3 \text{ kg for each inch over 5 feet}$
3. Lean Body Weight (LBW): The mass of non-fat tissues (muscle, bone, vital organs, blood volume), accounting for approximately $70 - 80%$ of TBW in non-obese individuals, but capped at $\approx 130% \text{ of IBW}$ in morbid obesity (Janmahasatian formula): $\text{LBW} \approx \text{IBW} \times 1.3$

---

2. Respiratory Pathophysiology: The Bariatric Mechanics Cascade

+-------------------------------------------------------------------------+
|                      BARIATRIC RESPIRATORY DYNAMICS                     |
+-------------------------------------------------------------------------+
| • Exponential Drop in Expiratory Reserve Volume (ERV ↓↓)                |
| • Functional Residual Capacity (FRC ↓↓) Falls Below Closing Capacity    |
| • Decreased Chest Wall Compliance (Excess Adipose on Thoracic Cage)     |
| • Decreased Lung Compliance (Alveolar Atelectasis & Increased Blood Vol)|
| • Increased Work of Breathing (Up to 4-fold increase in O₂ cost)        |
| • Elevated Basal O₂ Consumption (VO₂) and CO₂ Production (VCO₂)         |
+-------------------------------------------------------------------------+

                    [FRC AND ERV REDUCTION IN MORBID OBESITY]

         Non-Obese Healthy Adult (70 kg)       Morbidly Obese Adult (140 kg)
       +------------------------+             +------------------------+
       | Inspiratory Capacity   |             | Inspiratory Capacity   |
       | (IC ≈ 3500 mL)         |             | (IC ≈ 2800 mL)         |
       |                        |             |                        |
       +------------------------+             +------------------------+
       | Expiratory Res. Volume |             | ERV (↓ SEVERELY ~250mL)|
       | (ERV ≈ 1100 mL)        |             +------------------------+
       +------------------------+ <--- FRC ---+ Residual Volume        |
       | Residual Volume        |    (↓ 50%)  | (RV ≈ 1200 mL)         |
       | (RV ≈ 1200 mL)         |             |                        |
       +------------------------+             +------------------------+

The Safe Apnea Time Collapse

• Non-Obese Healthy Adult: Following $100% \text{ O}_2$ preoxygenation (denitrogenation), safe apnea time before $SpO_2$ falls below $90%$ is $6 - 8 \text{ minutes}$.
• Morbidly Obese Patient: Safe apnea time is dramatically reduced to less than $2 - 2.5 \text{ minutes}$.
• Mechanism: A severely compressed oxygen reservoir (depleted FRC) combined with a high rate of continuous oxygen consumption ($VO_2$ elevated due to metabolic mass of fat and increased respiratory muscle effort) causes rapid alveolar oxygen depletion.

Obstructive Sleep Apnea (OSA) vs. Obesity Hypoventilation Syndrome (OHS)

+---------------------------------------------------------------------------------------------------------+
|                                 OSA VS. OBESITY HYPOVENTILATION SYNDROME (OHS)                          |
+-----------------------+--------------------------------------+------------------------------------------+
| Feature               | Obstructive Sleep Apnea (OSA)        | Obesity Hypoventilation Syndrome (OHS)   |
+-----------------------+--------------------------------------+------------------------------------------+
| **Definition**        | Repetitive partial/complete upper    | Triad: Obesity ($BMI > 30$), awake       |
|                       | airway collapse during sleep         | daytime hypercapnia, and sleep apnea     |
+-----------------------+--------------------------------------+------------------------------------------+
| **Daytime Arterial Gas| **Normal** ($PaCO_2 < 45 \text{ mmHg}$| **Abnormal:** Daytime **$PaCO_2 > 45$**  |
|                       | with normal serum $HCO_3^-$)         | with elevated compensatory $HCO_3^-$     |
+-----------------------+--------------------------------------+------------------------------------------+
| **Ventilatory Drive** | Intact daytime central response to   | **Blunted central hypercapnic drive**;   |
|                       | $CO_2$; arousal breaks obstruction   | relies heavily on hypoxic drive          |
+-----------------------+--------------------------------------+------------------------------------------+
| **Cardiopulmonary**   | Episodic nocturnal hypoxemia and     | **Severe Pulmonary Hypertension**, RVH,  |
|   **Complications**   | systemic hypertension                | cor pulmonale, polycythemia, heart fail. |
+-----------------------+--------------------------------------+------------------------------------------+

The STOP-Bang Questionnaire for OSA Risk Stratification

+-------------------------------------------------------------------------+
|                         STOP-BANG OSA ASSESSMENT TOOL                   |
+-------------------------------------------------------------------------+
|  **S** - Snoring: Do you snore loudly (louder than talking/through door)?|
|  **T** - Tired: Do you often feel tired, fatigued, or sleepy during day?|
|  **O** - Observed: Has anyone observed you stop breathing during sleep?  |
|  **P** - Pressure: Do you have or are you being treated for High BP?    |
|  **B** - BMI: Is your Body Mass Index > 35 kg/m²?                       |
|  **A** - Age: Are you older than 50 years of age?                       |
|  **N** - Neck Circumference: Is neck > 40 cm (16 in) [>43 cm (17 in) ♂]?|
|  **G** - Gender: Is the patient Male?                                   |
+-------------------------------------------------------------------------+

$\text{Risk Strata: } 0 - 2 = \text{Low Risk}, \quad 3 - 4 = \text{Intermediate Risk}, \quad \mathbf{\ge 5 = \text{High Risk for Severe OSA}}$

---

3. Cardiovascular Pathophysiology in Morbid Obesity

• Expanded Blood Volume: Although total blood volume is increased in obesity, blood volume per unit mass is lower than in lean adults (approximately $45 - 50 \text{ mL/kg}$ TBW compared to $70 \text{ mL/kg}$ in lean adults). Adipose tissue receives approximately $2 - 3 \text{ mL}/100\text{g}/\text{min}$ of blood flow.
• Cardiac Output: Increases linearly by approximately $20 - 30 \text{ mL/min}$ per kilogram of excess adipose tissue, mediated entirely through increased stroke volume (resting heart rate is typically normal or slightly elevated).
• Ventricular Remodeling:
  • Left Ventricle: Chronic volume overload induces eccentric LV hypertrophy; concomitant systemic hypertension induces concentric LV hypertrophy, culminating in severe diastolic and systolic dysfunction.
  • Right Ventricle: Chronic nocturnal obstruction, hypercapnia, and respiratory acidosis cause recurrent hypoxic pulmonary vasoconstriction (HPV), leading to irreversible pulmonary arteriolar remodeling, pulmonary arterial hypertension (PAH), and right ventricular failure (cor pulmonale).

---

4. Anesthetic Pharmacology & Master Dosing Matrix

Administering medications in morbidly obese patients based strictly on Total Body Weight (TBW) leads to life-threatening overdoses of lipophilic anesthetics and muscle relaxants, whereas underdosing on Ideal Body Weight (IBW) can cause inadequate neuromuscular blockade or awareness under anesthesia.

+---------------------------------------------------------------------------------------------------------+
|                                MASTER BARIATRIC DRUG DOSING MATRIX                                      |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Drug & Class        | Dosing Weight     | Recommended Dosing  | Pharmacokinetic & Clinical Rationale    |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Propofol**        | **Lean Body**     | 1.5 - 2.0 mg/kg LBW | Induction on TBW causes severe vaso-    |
| (Induction)         | **Weight (LBW)**  |                     | dilation, myocardial depression & arrest|
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Propofol**        | **Total Body**    | 100 - 200 mcg/kg/min| High volume of distribution and         |
| (Maintenance/TIVA)  | **Weight (TBW)**  | TBW                 | accelerated metabolic clearance in fat  |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Succinylcholine** | **Total Body**    | **1.0 - 1.5 mg/kg** | **Pseudocholinesterase activity and ECF |
| (Depolarizing NMB)  | **Weight (TBW)**  | **TBW**             | volume increase in direct proportion to |
|                     |                   |                     | TBW; dosing on IBW risks sub-paralysis**|
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Rocuronium /**    | **Ideal Body**    | Intubation:         | Dosing on TBW results in excessive drug |
| **Vecuronium /**    | **Weight (IBW)**  | 0.6 - 1.2 mg/kg IBW | concentration at neuromuscular junction,|
| **Cisatracurium**   |                   | (Roc); 0.1 mg/kg Vec| severely prolonging duration of block   |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Sugammadex**      | **Total Body**    | 2, 4, or 16 mg/kg   | **Encapsulation requires 1:1 molecular  |
| (NMB Reversal)**    | **Weight (TBW)**  | **TBW**             | binding of relaxant in central & periph |
|                     |                   |                     | compartments; dosed on actual TBW**     |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Neostigmine**     | **Ideal Body**    | 0.04 - 0.07 mg/kg   | Dosed on IBW to avoid excessive cholinergic|
|                     | **Weight (IBW)**  | IBW (max 5 mg)      | muscarinic toxicity and bradycardia     |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Fentanyl /**      | **Lean Body**     | Bolus: 1-2 mcg/kg   | Rapid distribution into fat, but delayed|
| **Sufentanil**      | **Weight (LBW)**  | LBW; Infusion on LBW| elimination causes accumulation & apnea |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Remifentanil**    | **Lean Body**     | 0.05 - 0.2 mcg/kg/  | Rapidly cleared by non-specific blood/  |
|                     | **Weight (LBW)**  | min LBW             | tissue esterases; does not accumulate   |
+---------------------+-------------------+---------------------+-----------------------------------------+
| **Desflurane**      | Inhalational      | Titrate to MAC      | **Lowest blood-gas (0.42) & fat-gas     |
|                     |                   |                     | solubility; fastest, most predictable   |
|                     |                   |                     | emergence in bariatric surgery**        |
+---------------------+-------------------+---------------------+-----------------------------------------+

---

5. Airway Management, Positioning & Ventilatory Strategy

The Ramped / HELP Position

• In the supine position, excess adipose tissue on the upper back, shoulders, posterior neck, and chest forces the head into deep flexion, severely obscuring the line of sight during direct or video laryngoscopy.
• Head-Elevated Laryngoscopy Position (HELP / Ramped Position):
  • Elevate the upper torso, shoulders, head, and neck using folded blankets, foam ramps, or motorized table adjustments.
  • The Gold Standard Alignment Landmark: An imaginary horizontal line must connect the sternal notch directly with the external auditory meatus (tragus of the ear).
  • This alignment opens the pharyngeal axis, improves mask ventilation mechanics, aligns the visual line of sight with the laryngeal inlet, and expands chest excursion.

                         [THE RAMPED / HELP POSITION]

         [Tragus / External Auditory Meatus]
                         o  .  .  .  .  .  .  .  .  .  .  .  .  [Sternal Notch]
                        / \                                            |
                       /   \                                           |
                      /     \========[ Ramp / Elevation ]              v
                     /                                          ================
    [Head & Neck Elevated]                                      [Horizontal Plane]

Preoxygenation & Induction Technique

• 25° - 30° Head-Up Position: Increases FRC by removing the weight of the abdominal pannus from the diaphragm.
• CPAP / PEEP Preoxygenation: Applying $5 - 10 \text{ cmH}_2\text{O}$ CPAP via a tight mask seal during $3 - 5 \text{ minutes}$ of tidal breathing with $100% \text{ O}_2$ prevents atelectasis and extends safe apnea time by up to $50%$.
• Video Laryngoscopy (VL): Strongly recommended as the primary first-line intubation device for morbidly obese patients.

Intraoperative Lung-Protective Mechanical Ventilation

• Tidal Volume ($V_T$): Must be calculated strictly based on Ideal Body Weight (IBW) at $6 - 8 \text{ mL/kg IBW}$ (NEVER Total Body Weight, which causes severe volutrauma and barotrauma).
• PEEP: Apply $8 - 12 \text{ cmH}_2\text{O}$ PEEP to maintain patency of dependent alveoli.
• Alveolar Recruitment Maneuvers: Intermittent sustained inflations ($30 - 40 \text{ cmH}_2\text{O}$ for $10 - 15 \text{ seconds}$) re-expand atelectatic lung units, followed immediately by restoration of adequate PEEP.
• Driving Pressure ($P_{plat} - \text{PEEP}$): Maintain $<15 \text{ cmH}2\text{O}$ and maintain plateau pressure ($P{plat}$) $<30 \text{ cmH}_2\text{O}$.

Emergence & Extubation Protocol

1. Full Neuromuscular Reversal: Confirm quantitative train-of-four ratio $\text{TOF} \ge 0.90$ (preferably using Sugammadex dosed on TBW).
2. Positioning: Extubate in the reverse Trendelenburg (30° - 45° head-up) or fully seated position.
3. Awake Criteria: Patient must be completely awake, responsive to commands, with return of protective airway reflexes and regular spontaneous tidal volumes.